To examine the genetic contribution of HLA and non-HLA genes in the etiopathogenesis of rheumatoid arthritis (RA), 60 Caucasian multiplex families were identified and DNA analyzed for over 52 markers including DRB1, DQA1 and DQB1 alleles. Many of the markers were chosen because of close proximity to candidate genes suggested by previous studies or models of pathogenesis. Sibling pair analysis (SIBPAL), relative pair analysis (RELPAL) and linkage studies using two different models of inheritance suggested linkage for the MHC and two additional chromosomal regions: chromosome 2 (D2S443 near CD8 and IG; 2p13-2p11.1), and chromosome 15 (CYP19-estrogen synthase; 15q15). No support was found for two chromosomal regions, 1p36 and 3q13, recently suggested by other studies. We used transmission disequilibrium testing (TDT), conditional logistic regression, and segregation analysis to study the contributions that the shared epitope and TNF-c have in contributing to risk for RA. These studies provide additional evidence that the association of HLA alleles in RA patients from multiplex families is similar to that observed in sporadic disease, suggest candidate regions for further analysis and find additional support for an association of TNF-c alleles with RA susceptibility.
Introduction
A variety of evidence suggests that susceptibility to rheumatoid arthritis (RA) is in part determined by genetic predisposition. Twin studies show several-fold higher levels of concordance in identical compared with nonidentical twins 1 and first-degree relatives have an agestandardized relative risk of approximately 8 compared with unrelated individuals within similar populations. 2 However, only analyses of the MHC region have provided convincing support for genetic loci that are critical in the etiopathogenesis of RA. The initial MHC studies by Stastny 3 showing an association of RA with HLA-DR4 have subsequently been confirmed in multiple ethnic groups 4 with some exceptions. [5] [6] [7] Further analyses of these HLA associations have indicated that the majority of RA-associated HLA-DRB1 alleles share a common structural feature at positions 70-74 of the DRB1 chain: Q K R A A (DRB1*0401) or Q R R A A (DRB1*0404, 0405, 0408, 0101, 1402) or R R R A A (DRB1*1001). This finding has given rise to the shared epitope hypothesis. Additional hypotheses suggesting an important role for DQ alleles or protective effects of DRB1 alleles have also been advanced. 9, 10 Another recent study strongly suggests that the TNF gene linked to the MHC is also an independent susceptibility gene 11 but this has not been supported in other studies 12, 13 that were performed on different populations and used different methods. Further studies will be needed to understand the relative importance of specific alleles in disease susceptibility and severity. Estimation of the genetic contribution of HLA suggests that less than 40% of RA susceptibility can be attributed to MHC-linked genes. 14, 15 Multiple studies have reported a possible association or linkage with a variety of non-MHC genes and loci, most notably the T cell receptor B chain. Positive population associations with TCRB alleles have been reported by some groups, 16, 17 but not others. 18, 19 These conflicting results could be due to the confounding effects of population stratification and the discontinuity of linkage disequilibrium across the entire TCRB complex. 20 A single linkage study using the affected sibling (sib) pair method, found increased sib pair sharing for several specific TCRBV regions. 21 Other studies have found a significant but weak association of a TCR␣ chain polymorphism with RA. 22 Recent studies indicate possible linkage of RA with several other non-MHC loci or genes, [23] [24] [25] [26] but none have been independently confirmed. The current study represents our initial studies of a substantial collection of multiplex RA families. Our goals are to ascertain both the role of the MHC in familial RA and to identify candidate novel loci that will stimulate additional analyses in other data sets.
Results
Linkage studies of candidate genes and chromosomal regions To identify loci that are linked to RA susceptibility genes, both molecular HLA (DRB1, DQA1 and DQB1) and highly polymorphic markers (microsatellites) in over 40 chromosomal regions were typed in a total of 190 subjects from 60 multiplex RA families that included 48 affected sibling pairs. Most of the 40 chromosomal regions were selected to include putative candidate genes as shown in Table 1 . Each family had at least two affected individuals who met ACR criteria for RA and included 48 full sibling pairs concordant for disease. HLA typing indicated that for the 142 affected members in these families, 68 had one copy of the shared epitope, 35 had two copies of the shared epitope and 39 did not possess a shared epitope.
To assess linkage, a sibling pair analysis was first performed using the SIBPAL algorithms. Nominal levels of significance were reached for five different chromosomal regions including: the MHC; TCRB; and markers on chromosome 2 (D2S443 near CD8 and IG, and D2S273; 2p13-2p11.1) and chromosome 15 (CYP19-estrogen synthase; 15q15). For the MHC region, several loci achieved significant scores in affected sibling pairs including: DQA1, P = 0.046; DQB1, P = 0.053; TNF-b, P = 0.006; and TNFc, P = 0.007, with approximately 60% sharing of alleles in affected pairs (Table 1) . Similarly affected sibling pairs showed significant scores for D2S443 (P = 0.027) and CYP19 (P = 0.022) ( Table 1) . For TCRB and D2S273, significant scores were observed only in unaffected sibling pairs (P = 0.017 and P = 0.042, respectively).
A relative pair analysis was also used to assess linkage in this data set that included additional family members (Table 1 ). This analysis provided stronger evidence in support of linkage for most of the MHC region markers; DRB1, P = 0.002; DQA1, P = 0.044; DQB1, P = 0.001; and TNF-b, P = 0.004. Similar levels of significance were obtained for two of the non-MHC markers that were suggested by the sibling pair analyses: D2S443, P = 0.031; and CYP19, P = 0.056. Three additional markers, D1S1153, D2S114 and D10S521 were also suggested. No linkage was observed for multiple potential candidate region genes using either the sibling pair or relative pair analysis including those for: CD28, CD80, CD86, FcGR1, IL2, IL3, IL5, IL10, IL14 and IL5RA (Table 1) .
Further analysis was also performed using both dominant and recessive models in which penetrance of RA susceptibility was set to 15% for male carriers and 30% for female carriers. Significant linkage (P Ͻ 0.05) was found for both D2S443 and CYP19 (Table 2) . For the recessive model under a homogeneous model in which all of the families are assessed to have the same susceptibility alleles, the maximum LOD scores for D2S443 (LOD = 0.894) and CYP19 (LOD = 0.774) were similar to those observed for the MHC class II loci: DQA1 (LOD = 0.878), DQB1 (LOD = 0.947), DRB1 (LOD = 0.751), and DR (LOD = 1.14). No evidence of linkage was observed for other markers suggested by the RELPAL algorithm (D1S1153, D2S114, and D10S521).
Evidence for independent effect of TNF-c
The studies presented above showed linkage to both class II and class III MHC loci. Since a previous study has suggested linkage of TNF-c that was independent of the shared epitope, we utilized several modeling schemes to assess potential independent effects of the alleles of TNF-c vs the shared epitope. First, the effects of TNF-c and the shared epitope were assessed singly using a TDT analysis. Using a Fisher exact test, the results showed significant effects of both the shared epitope (31.5 alleles transmitted vs 11.5 alleles not transmitted, P = 0.002, with an odds ratio of 2.74) and TNF-c (33 TNF-cl alleles transmitted vs 16 not transmitted, P = 0.02 with an odds ratio of 2.06).
For joint consideration of both TNF-c and the shared epitope, conditional logistic regression was utilized. For this analysis, whenever one parent was missing and the remaining parent and child were heterozygous, weights were assigned to the possible outcomes: if both parent and child were heterozygous for both loci, we assigned one quarter weight to each of the four possible transmissions. Similarly, if the parent-child pair were heterozygous for only one locus, we assigned one half weight to each of the uncertain transmissions. Whenever both parents were available or either a parent or child in a parent-child pair was homozygous, we were able to assign unit weight to the observed transmission of an allele to the affected offspring. Joint analysis via conditional logistic regression showed a borderline significant effect of TNF-c independent from shared epitope (P = 0.056, odds ratio = 2.1) but not of the shared epitope (P = 0.50, odds ratio = 1.41).
Segregation studies were used as a secondary analysis to assess the joint effects of TNF-c and the shared epitope. In this analysis we treated the rheumatoid arthritis observations as outcomes, with presence of either the shared epitope or TNF-c and the sex of an individual as predictors. Genetic models were fitted under a logistic function that assumes that the affection risk is a linear function of the inferred genotype of an individual and the predictors. To assess the significance of each predictor, a likelihood ratio test was utilized. This test was defined as the likelihood of disease occurrence under a null model in which a predictor is eliminated compared to the likelihood under an alternate model in which that predictor is included. The results from this segregation analysis showed a trend for effects from both TNF-c and the shared epitope. Analyses of TNF-c and the shared epitope singly showed significant effects for the TNF-c. The estimate of the odds ratio for TNF-c was 1.78 ( 2 = 16.09, P = 6 × 10 −6 ) and for the shared epitope the estimated odds ratio was 1.63 ( ). From the joint analysis, the estimate of the odds ratio was 1.65 for TNF-c ( 2 = 4.06, P = 0.04) and for the shared epitope, 1.91 ( 2 = 3.08, P = 0.08). Female sex was associated with an odds ratio of 1.97. These results are consistent with independent effects of both TNF-c and shared epitope on risk for rheumatoid arthritis. These results were similar to those obtained using logistical regression. However, in segregation analysis we used the entire pedigree structure in the analysis rather than just affected children and their parents, who were used for the TDT and conditional logistic regression analyses. well as significant association for the TNF-c polymorphism. Together, these results strongly suggest that the effect of the HLA-DRB1 polymorphisms and the shared epitope is similar to that observed in 'sporadic' disease.
More controversial is the observation that TNF-c polymorphisms may confer a risk independent of that observed for the shared epitope. The studies by Mulcahy 11 strongly suggested that the TNF-c1 allele was an independent risk factor. Both a logistical regression analysis and segregation studies favored an association with TNF-c1 independent of the shared epitope in the current study. Thus, our results using a completely different data set than Mulcahy, 11 and a different analytic strategy, provide support for the hypothesis that a second MHC-associated risk factor is important in some populations. Opposing studies have either failed to show any independent effect of TNF polymorphisms 12, 13 or only an association with severity of disease. 28, 29 The inconsistency between these studies may reflect study differences including the populations analyzed and analytic methods used as well as the average age of the affected subjects and severity of disease. It is of possible importance that both the current study and the study of Mulcahy 11 were primarily composed of families from Ireland.
It should be noted that it is the TNF-c2, not TNF-c1, polymorphism which has been shown to be in linkage disequilibrium with a TNF promoter variant that is associated with increased TNF production in response to some pro-inflammatory stimuli. 30 Thus both our results and those of Mulcahy 11 show a seemingly paradoxical association with a low TNF-producing polymorphism. This raises the question as to whether the independent effect may be due to another MHC-linked gene(s). Other MHC region genes linked to RA include HLA-DMA, HLA-DMB and polymorphisms in prolactin microsatellites. 31, 32 While the latter was in linkage disequilibrium with DRB1 in the population studied, the DMA effects appeared to be independent of DRB1. Additional studies examining more MHC region polymorphisms will be necessary to allow further elucidation of the role of other non-class II genes. However, these results may in part explain the variable effect of the shared epitope and specific DRB1 alleles that are seen in different populations. 5, 6 Several non-MHC region loci were also linked to RA in the current analysis. These must be regarded as only suggestive since the results only reach statistical significance when considered alone. It is notable that a similar level of significance to that of the MHC loci was achieved for two of the non-MHC region loci, D2S443 (on chromosome 2 near CD8 and IG; 2p13-2p11.1), and CYP19 (15q15), using sibling pair analyses and model-dependent linkage analysis.
In contrast to the sib pair analysis, the relative level of significance for D2S443 and CYP19 compared with MHC loci was much lower when a relative pair analysis was performed. Also, markers in two additional non-MHC regions, D1S1153 (Chr 1 at 170 cM near CD2, CD1, IL6R, CD48 and FcGR2/3; 1p12-1q21) and D10S521 (Chr 10 at 131 cM near FAS; 10q23-10q24), reached nominal levels of significance using relative pair analysis but did not in the sib pair studies. The differences in the SIBPAL and RELPAL results may reflect the sensitivity of the RELPAL algorithm to dominant factors segregating in the complete family and the inclusion of unaffected individuals in the analysis. The LOD score analysis under a dominant model failed to confirm effects from D1S1153 and D10S521 suggesting that these results reflect spuriously positive findings from RELPAL.
Finally, it is notable that two other regions, TCRB and D2S273, reached nominal levels of significance in the sibling pair studies, but only in unaffected sib pairs. The lack of linkage in affected sibling pairs raises the question of whether these results are the consequence of fully penetrant susceptibility alleles or are spurious positive findings.
Association was also examined for those markers suggested by the linkage results. In contrast to the MHC loci, TDT analyses of these markers did not show an association (data not shown). This suggests that these loci, if confirmed in additional linkage studies, are markers for susceptibility genes in these regions that are not in linkage disequilibrium with the true susceptibility genes. For association-based tests like TDT, markers at very closely adjacent chromosomal positions may be necessary for positive tests in most populations.
Other non-MHC candidate regions including the IDDM9 region of chromosome 3 and the proximal region of human chromosome 1 suggested in other preliminary studies, 23, 25 were not confirmed in the current study. Similarly, these studies did not find a significant linkage for candidate loci suggested in the current study. Another putative susceptibility locus at Xq27 recently suggested 25 was not examined in the current study. Of additional note, another report 33 has provided some support for our initial studies suggesting linkage with CYP19 at 15q15. 26 This study examining 200 sib pairs found marginal linkage between RA and CYP19 (P = 0.04). 33 However, the general failure to confirm suggestive results in different data sets may reflect the relatively low power for linkage methods to detect complex disease loci that may confer genotypic risk ratios of less than 4-fold. Much larger linkage sets including the current efforts by several groups are necessary to provide more definitive results. 34 Furthermore, the use of case-controlled association or family-based association techniques (eg TDT) may be necessary for uncovering and confirming loci with relatively small genotypic risks. 35 This may account for the lack of linkage in the current study or previous linkage studies for candidate genes such as IL10 suggested using association methods. 36 Conversely, the association analytic strategies may require very close proximity between the susceptibility gene (ie 1 cM in non-founder populations) and the marker studied. This is in contrast to linkage methods that are not very sensitive to small chromosomal intervals (ie linkage can be detected for Ͼ 10 cM intervals). The current study identifies additional loci that should be included in future studies of RA to further define this complex genetic disease.
Patients and methods

Subjects
A total of 60 multiplex Caucasian families was identified in which at least two members met ACR criteria for the diagnosis of RA. 37 These families consisted of 47 from Northern Ireland, 10 from Newcastle, United Kingdom, and three from the USA. Of the 142 affected individuals from these families who were included in the analysis, 122 were rheumatoid factor (RF) positive, 52 had nodular disease and 114 had documented erosions on hand films. We obtained documentation of either a positive RF or rheumatoid nodules from a total of 133 of the 142 affected patients studied. There were 104 females and 38 males and the average age (± SD) of disease onset was 40.3 ± 13.7 years of age. In addition, 48 unaffected family members were also ascertained for determining identity by descent and linkage analyses.
Sample preparation
DNA templates for PCR analyses were prepared either from peripheral blood mononuclear cells using modifications of standard techniques 38 or prepared from buccal cell brushings. Briefly, for buccal cell DNA, after brushing the cheek mucosal surfaces, brushes were placed in 600 l 50 mm NaOH and heated at 95°C for 10 min. After vortexing, the brush was discarded and the sample neutralized with 50 l of 1.0 m Tris/HCl, pH 8.0. Following brief centrifugation (14 000 rpm for 1 min), the suspension was transferred to new tubes and stored as stock solutions at 4°C (no loss of DNA in empirical studies over 3 years). For working solutions, stock DNA was sheared and resuspended in T10E1 at a 1-4 dilution and typical PCR reactions utilized 1 l of this working solution.
HLA typing
Oligotyping was performed by PCR amplification using generic and family or subtype-specific primers and an ELISA, using fluorescein-labeled, sequence-specific oligonucleotide probes, as previously described. 39 Primers and probes target the same sequences used in the 11th and 12th International Histocompatibility Testing Workshops. 40, 41 DNA marker analyses A set of 47 polymorphic microsatellite markers with an average heterozygosity of 0.85 was selected from candidate gene regions as an initial part of a genome-wide screening effort. Most markers were obtained from Research Genetics, Inc (Huntsville, Al, USA) with forward-primers already labeled with one of the four fluoromores (HEX, TET, 6-FAM, JOE phosphormidites). Some of the tetranucleotide repeat markers were kindly provided by Drs L Ballard and R White of the University of Utah. Other markers were selected from published sequences and synthesized commercially (Department of Plant Biology, Duke University, Durham, NC, USA). For the latter, forward markers were tagged with a fluorescent dye using a standard aminolink protocol (ABI manual). Polymerase chain reactions (PCR) were performed in 96-well microtiter plates in a 5-l reaction volume using 10 ng of sheared human DNA, 0.5 l of 10 × reaction buffer (Perkin-Elmer Cetus, Norwalk, CT, USA), 125 m of each dNTP, 8 m of forward and reverse primers, and 0.25 U of Taq DNA Polymerase (Bethesda Research Laboratories, Gaithersburg, MD, USA). BIOOVEN III (Biotherm Corporation) or GeneAmp PCR System 9600 (Perkin-Elmer Cetus) were used for PCR, using mostly Weissenbach conditions (92°C for 5 min, followed by 35 cycles of 40 s at 92°C, 30 s at 55°C, and a final extension of 2 min at 72°C), with some variations made in the annealing temperatures, MgCl 2 concentration, and number of cycles performed to optimize the individual marker conditions.
Pooling and multiplexing PCR products
In order to maximize efficient typing, a multiplex protocol similar to those described previously 42 was used for many of the markers. Groups of 8-12 markers labeled with three different dyes (FAM, TET, HEX or FAM, JOE, TAMRA) were pooled together for multiplexing. Internal lane size standards (GeneScan 500-ROX for filter A or GeneScan 500-TAMRA for filter B), 1.25 l of formamide and 0.25 l of loading dye were mixed with one tenth volume of the pooled PCR product from each sample. After denaturing at 93°C for 2 min and quick chilling on ice, samples were loaded onto 7% polyacrylamide/7 m urea gels (Sooner Scientific, Inc, Garrin, OK, USA) with 0.1% APC and TEMED. Thirty-six samples were run together on 12-cm gels and electrophoresed in 1 × TBE for 3-4 h using a 373A DNA Sequencer (Applied Biosystems, Foster City, CA, USA). For semi-automated data collection and analysis, 672 GeneScan Collection Software (Version 1.1) was used (Applied Biosystems).
Allele assignment and analysis DNA fragment analysis software Genotyper Version 1.1 (Applied Biosystems) was used for semi-automated allele size assignment in basepairs according to the manufacturer's manual. The allele size of each PCR product was determined in reference to internal lane size standards. Allele sizes were rounded off to a discrete whole number and checked for inheritance and presence of an extra allele in nuclear families. Marker data were initially processed using the program PEDSYS 43 to identify any marker inconsistencies.
Linkage analysis
To identify genetic linkages we used both affected sib pair methods and model-dependent likelihood-based procedures. We used the SIBPAL module of SAGE 44 to evaluate the null hypothesis that identity by descent (ibd) sharing among sib pairs was 0.5 compared with an alternate hypothesis of deviation from 0.5. In sib pairs concordant for disease status, the influence of a genetic factor induces an excess sharing of alleles identical by descent, while in sib pairs discordant for disease status, genetic effects confer decreased allele sharing. For diseases with low penetrance, such as rheumatoid arthritis, affected sib pairs are most informative for detecting genetic factors. 45 The statistical analysis divides all sibships into all possible pairs, but then estimates the appropriate degrees of freedom for the test conditional upon correlations that may exist among the pairs (SAGE). 44 Sib pair analyses were restricted to include only full sib pairs, as only a very limited number of half-sib pairs were available for analysis and their inclusion could have decreased the reliability of our results, by increasing the sampling variability of test statistics. We also used the RELPAL program 44 which can include information from all relative pairs. For binary traits such as affection with RA, this procedure tests the ibd sharing for each class of relative pair among those concordant for disease with those individuals discordant for disease. After analyses are conducted within each type of relative pair, the results are combined using a weighting function that is proportional to the variance within each relative class. This variance can be estimated from the data or formed by consideration of the number of pairs of each type and by assuming no recombination between the marker and disease locus. We chose to use the latter method because with our somewhat limited sample size we were concerned about the generalizability of our findings, if a parameter had to be estimated from each type of relative that was studied. For any results that were found to be significant at the 0.05 level from either SIBPAL or RELPAL analysis, we also applied model-dependent linkage analysis. We assumed a genetic model for which the penetrance of susceptibility was 15% for male carriers and 30% among female carriers. These parameters were chosen according to analyses provided by Hasstedt et al 27 which yielded penetrances of 30% at age 50 for homozygous female carriers and 21% for homozygous male carriers for an HLAlinked locus. We assumed that the sporadic risk was 0.25% among males and 0.75% among females. These figures were chosen to provide an increased probability of disease occurrence in females, with a higher relative probability of disease for females not having inherited susceptibility. We fitted two models: for the dominant model we assumed a disease gene frequency of 2% and for the recessive model, we assumed a disease gene frequency of 14.1%. For females, these frequencies yield population prevalences of RA of about 2% and a risk to siblings of about 10.3% under the dominant model. Under the recessive model, the prevalence is 1.3% and the recurrence risk to female siblings is 4.3%. These recurrence risks fall within the range of risks provided in the summary manuscript of Rigby et al. 14 We used the package Analyze 46 to perform linkage analyses and homogeneity tests. 47 
Transmission disequilibrium testing
The TDT test was performed according to published methods. 48 These analyses were restricted to include only those markers that had been identified through sib pair linkage analyses as showing a potential genetic linkage. We first performed an omnibus test that any of the alleles were excessively transmitted to affected children by performing a marginal homogeneity test in which the mar-ginal probabilities for transmission and nontransmission of all alleles are jointly compared. To assess significance of the results, we permuted the observed transmission from parents to children randomly and resampled the data 1000 times to obtain empirical P-values. 11 For any loci that were found to show significant results, we subsequently evaluated evidence for preferential transmission of any alleles using all affected offspring for whom parental data were available, by applying McNemar's test and used Fisher's exact test to assess significance. Fisher's exact test was used to provide more accurate significance levels than can be obtained from application of the normal approximation to the binomial. For these analyses, parental alleles were first inferred from all available pedigree members, whenever data were missing. In the analysis, whenever one parent was missing and both the remaining parent and affected child were heterozygous for the allele, we scored one half allele both transmitted and not transmitted as suggested under the null hypothesis that there is no preferential transmission of either allele. For analyses of the shared epitope, any of the following alleles were classified as containing the shared epitope: DRB1*0401, 0404, 0405, 0408, 0101 or 1001. All other alleles were classified as not containing the shared epitope.
Analysis of joint effects of the shared epitope and TNF-c
Both logistic regression and segregation analysis were performed to assess the independent effects of the shared epitope and TNF-c. The conditional logistic regression analysis was performed using proc logistic in SAS (Statistical Analysis Software, Cary, NC, USA). The estimates of the effects of each predictor were assessed by forming the antilogit transformation of the coefficient for the predictor. As recently summarized by Schaid, 49 application of conditional logistic regression provides a TDT test, in this case, we used conditional logistic regression so that effects from multiple loci could be modeled. For segregation analysis, the REGD module of the Statistical Analysis for Genetic Epidemiology (SAGE) 44 was used. This approach allowed us to model the risk for RA jointly associated with TNF-c or the shared epitope, for all individuals in the pedigree (not just those individuals for whom parental genotype data are available). However, this approach does not condition on family membership and could be influenced by population heterogeneity, if present.
